The BD MAX Respiratory Viral Panel uses a single nasal or nasopharyngeal swab sample to determine if a patient has COVID-19, the flu or RSV. – BD Patients wondering whether they have COVID-19, the flu ...

FRANKLIN LAKES, N.J., Feb. 8, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received Emergency Use ...

(RTTNews) - Becton, Dickinson and Company (BDX) announced the BD MAX Respiratory Viral Panel, a combination test for SARS-CoV-2, Influenza A + B and Respiratory Syncytial Virus, has been CE marked to ...

BD (Becton, Dickinson and Company) recently expanded its European infectious disease diagnostics portfolio after IVDR certification of two Certest Biotec VIASURE assays for the fully automated BD MAX™ ...

FRANKLIN LAKES, N.J., Dec. 15, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the expansion of its respiratory and ...

FRANKLIN LAKES, N.J., June 30, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that the BD MAX™ Respiratory Viral Panel (RVP ...

BD announced the expansion of its respiratory and sexually transmitted infection diagnostics offerings in Europe following In Vitro Diagnostic Medical Device Regulation certification of two VIASURE ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced the expansion of its respiratory and sexually transmitted infection (STI) diagnostics portfolio in Europe. This follows the ...